FDA Drug Application (022161) for LEXISCAN by ASTELLAS

Back to FDA Applications sponsored by ASTELLAS

Application Number022161
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage0.4MG/5ML (0.08MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLEXISCAN
Active IngredientREGADENOSON



Back to FDA Applications sponsored by ASTELLAS